Clinical trials
Active, not recruiting Anemia, Refractory, with Excess of Blasts trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
5 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2012 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2023 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 5 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 3 |
| Celgene | 1 |
| McMaster University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Anemia, Refractory, with Excess of Blasts | 5 |
| Myelodysplastic Syndromes | 4 |
| Leukemia, Myelomonocytic, Chronic | 2 |
| Anemia | 1 |
| Bronchiolitis Obliterans Syndrome | 1 |
| GATA2 Deficiency | 1 |
| Leukemia, Myeloid, Acute | 1 |
| Myelodysplastic-Myeloproliferative Diseases | 1 |
| Myeloproliferative Disorders | 1 |
Trials
Showing 1 to 5 of 5. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.